Leman Biotech
PrivateLast Round
Series A
Extension
Mar 4, 2026
Total Funding Raised
$60M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Leman Biotech operates in Healthcare & Life Sciences and is based in Shenzhen. Its latest recorded funding round was a Series A Extension round in March 2026.
Leman Biotech is a biotechnology company that develops next-generation metabolic cancer immunotherapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Leman Biotech Comparables
Compare Leman Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ucello Biotechnology | 82% | |
| CARsgen Therapeutics | 77% | |
| IASO Bio | 76% |
For institutional investors. Book with your work email.
Leman Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 4, 2026 | ||||
| Series A | Nov 13, 2024 | ||||
| Angel | Jun 18, 2024 | ||||
| Angel | Jan 18, 2022 |
For institutional investors. Book with your work email.
Leman Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 中山创业投资有限公司 | Series A Extension |
| Fuhui Venture Capital | Angel |
| Tiantu Capital | Angel |
| Tailong Investment | Series A Extension |
| 5Y Capital | Angel |
| Zhongshan Venture Capital Co., Ltd. | Series A Extension |
| Yuecai Zhongyin Private Equity Fund Management | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 26, 2026
Grew 100% QoQ from 3 to 6 employees.
- Mar 4, 2026
$28M round led by XtalPi and Yuecai Zhongyin.
For institutional investors. Book with your work email.
Leman Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Leman Biotech's valuation, stock price, and market status.
Is Leman Biotech a public or private company?
Leman Biotech is a private company.
What is the current stock price of Leman Biotech?
Leman Biotech is a private company, so its shares have no public market price. Caplight tracks Leman Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Leman Biotech worth (valuation)?
Valuation information for Leman Biotech is not publicly available.
Can I buy Leman Biotech stock?
Leman Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Leman Biotech's last funding round?
Leman Biotech's most recent funding round was Series A Extension on March 4, 2026.
Who are the main investors in Leman Biotech?
Key investors in Leman Biotech include Tiantu Capital, Yuecai Zhongyin Private Equity Fund Management.
Will Leman Biotech IPO soon?
No public IPO plans have been announced for Leman Biotech.
How can I track Leman Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Leman Biotech's shares on secondary markets.